BeiGene, Ltd. (BGNE) PT Raised to $409 as Morgan Stanley More than Doubles Peak Brukinsa Sales Ahead of a NT Catalyst
Tweet Send to a Friend
Morgan Stanley analyst Matthew Harrison raised the price target on BeiGene, Ltd. (NASDAQ: BGNE) to $409.00 (from $357.00) after raising ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
